Karina Krøjer
Head of Asia Drug Development Lundbeck
Seminars
Thursday 10th December 2026
Neuroscience in Biopharma: Innovation Through Biology & De-Risking CNS Programs: Progress & Outlook
1:30 pm
- Exploring Lundbeck’s evolution and outlook within neuroscience
- Lundbeck R&D tactics for pipeline derisking through rigorous development process
- Spotlighting on Lundbeck’s pipeline innovation and importance of collaborations and partnerships to advance neuroscience
